Insights

From case studies to white papers to industry and company news, get a closer look at the work we do through our articles and other helpful resources.

Let's Collaborate

Featured

Benefits of Product Design Due Diligence for Successful Integration

Join Shital Patel, COO of ECI, as she shares insights on ensuring value creation through effective product design assessments during acquisitions. Perfect for professionals involved in M&A, product development, and quality assurance in the medical device industry. Thursday, September 26, 12pm EDT

read more

Posts

Showing 0 results
of 0 items.
highlight
Reset Filters

Type

Clear

Service

Clear

Industry

Clear
Case Study

FDA Mock Audit

A mock audit is often requested to assess a company's readiness for FDA inspection. This case study illustrates an example of an ECI mock audit in support of a medical device company's response to an FDA warning letter.

LEARN MORE
Case Study

Costa Rica Product Registration

A US medical device manufacturer requested regulatory support to register their products and obtain a Free Sales Certificate in Costa Rica. This case study provides an example of our company's ability to provide in-country representation for product registration in Costa Rica.

LEARN MORE
Case Study

Warning Letter: Post Market Surveillance Remediation

ECI was enlisted to guide a large medical device company through remediation planning and execution to comprehensively address FDA 483 observations and subsequent Warning Letter, due to deficiencies in post-market surveillance activities.

LEARN MORE
Case Study

Post Market Surveillance Resource Management

ECI was enlisted to guide a large medical device company through 483 Observation and Warning Letter remediation planning for post-market surveillance activities. In parallel to the remediation efforts, ECI also supported the company's acquisition by a competitor to ensure a seamless transition aligning the company's procedures for complaint processing and medical device reporting.

LEARN MORE
White Paper

Responding to FDA Objectionable Conditions: FDA-483s and Warning Letters

ECI released this white paper to better inform the medical device industry about how to most effectively respond to objectionable findings from the FDA generated as a result of Agency inspections or investigations.

LEARN MORE
No results found
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

ECI on LinkedIn & Twitter

Let's connect! Follow along for updates from our expert team on everything from industry trends to technology breakthroughs to the latest news on all things ECI.

Our Reliable Solutions

ECI offers clients diverse perspectives, proven experience, and vital confidence in the face of daunting challenges. Learn more about trusted solutions we’ve developed to address a variety of compliance needs.

Explore Solutions

Let Us Help

You focus on your business. We focus on the momentum of the industry and help you keep pace across your portfolio.

Contact US